Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verde Science Inc VRCI

Healthcare Biotechnology
Verde Science, Inc. is a pharmaceutical research and development company. The Company is engaged in medical science consulting business. The Company is focused on the discovery of drugs and treatment modalities, as well as diagnostic devices and pharmaceutical delivery systems for the treatment of diseases and medical issues. The Company is focused on developing medicinal formulations from cannabinoids and tetrahydrocannabinol (THC) compounds for the treatment of various issues, such as migraines, glaucoma, loss of appetite from cancer therapies, and other medical issues. The Company is focused on launching its THC Pharmaceutical Development Program by executing a research program, which involves developing formulations preparing protocols for clinical trials.


GREY:VRCI - Post by User

Verde Science Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(9)
•••
Post by GUNSSon Aug 22, 2013 5:29pm
204 Views
Post# 21690930

Monday, Aug 26th Conf Call

Monday, Aug 26th Conf Call
MINERAL WELLS, TEXAS--(Marketwired - Aug. 22, 2013) - Rango Energy, Inc. (RAGO) will host an investor conference call on Monday, August 26, 2013 at 2:00 pm EST to provide a drilling update on its current well at Kettleman Middle Dome ("KMD") in the San Joaquin Valley, and additional details on it previously announced Letter of Intent to acquire Hangtown Energy, Inc.

Vince Ramirez, Hangtown's CEO and Chief Geologist, and Harp Sangha, Rango Chairman and CEO, will host the presentation, followed by a question and answer session.

Date: Monday, August 26, 2013
Time: 2:00 pm ETUS Dial-In: 877-941-2068
International Dial-In: 480-629-9712
Conference ID: 4637183

Webcast: https://public.viavid.com/index.php?id=105892
A playback of the call will be available until 11:59 pm ET on September 9, 2013. To listen, call +1-877-870-5176 within the United States or +1-858-384-5517 when calling internationally. Please use the replay PIN number 4637183. The playback of the call will also be made available on the investor relations section of the Company's website.

About Rango Energy

Rango Energy, Inc. is an exploration stage oil and natural gas company with a strategy to identify, evaluate, explore, and develop new opportunities for oil and natural gas production across North America.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities